Work

Safety and efficacy of sintilimab versus pembrolizumab in the treatment of advanced or recurrent pediatric malignancies: A real-world study in China.

Year: 2025

Type: article

Study design: Observational Study

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e22010

Authors: Lei Mao, Juan Wang, Mengjia Song, Yi Que, Yu Zhang, Feifei Sun, Jia Zhu, Junting Huang, Suying Lu, Zijun Zhen, Yizhuo Zhang

Institutions: Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410815069

FWCI:

Cites:

Cited by:

Related to: 10